Friday, March 31, 2023 | Back issues
Courthouse News Service Courthouse News Service

Securities Complaint Against Pfizer Dismissed

MANHATTAN (CN) - A federal judge has dismissed a class-action securities complaint against Pfizer, whose share price dropped by 11 percent after it suspended testing of its anti-cholesterol drug torcetrapib late in2006.

Judge Lewis Kaplan found that lead plaintiffs the Uniformed Sanitationmen's Association Accrual Fund "have not pleaded with particularity facts sufficient to support their allegation that defendants' statements were materially misleading."

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.